The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page; Joanne E. McKenzie; Patrick M. Bossuyt; Isabelle Boutron; Tammy C. Hoffmann; Cynthia D. Mulrow; Larissa Shamseer; Jennifer M. Tetzlaff; Elie A. Akl; Sue E. Brennan; Roger Chou; Julie Glanville; Jeremy M. Grimshaw; Asbjørn Hróbjartsson; Manoj M. Lalu; Tianjing Li; Elizabeth W. Loder; Evan Mayo-Wilson; Steve McDonald; Luke A. McGuinness; Lesley A. Stewart; James Thomas; Andrea C. Tricco; Vivian A. Welch; Penny Whiting; David Moher

doi:10.1016/j.ijsu.2021.105906

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt, Isabelle Boutron, Tammy C. Hoffmann, Cynthia D. Mulrow, Larissa Shamseer, Jennifer M. Tetzlaff, Elie A. Akl, Sue E. Brennan, Roger Chou, Julie Glanville, Jeremy M. Grimshaw, Asbjørn Hróbjartsson, Manoj M. Lalu, Tianjing Li, Elizabeth W. Loder, Evan Mayo-Wilson, Steve McDonald, Luke A. McGuinnessLesley A. Stewart, James Thomas, Andrea C. Tricco, Vivian A. Welch, Penny Whiting, David Moher

Research output: Contribution to journal › Article › Other › peer-review

6302 Citations (Scopus)

Abstract

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.

Original language	English
Article number	105906
Number of pages	9
Journal	International Journal of Surgery
Volume	88
DOIs	https://doi.org/10.1016/j.ijsu.2021.105906
Publication status	Published - Apr 2021

Access to Document

10.1016/j.ijsu.2021.105906Licence: CC BY

Cite this

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. International Journal of Surgery, 88, Article 105906. https://doi.org/10.1016/j.ijsu.2021.105906

@article{f108cce6519a4286bcadc050fbe26d9c,

title = "The PRISMA 2020 statement: An updated guideline for reporting systematic reviews",

abstract = "The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.",

author = "Page, {Matthew J.} and McKenzie, {Joanne E.} and Bossuyt, {Patrick M.} and Isabelle Boutron and Hoffmann, {Tammy C.} and Mulrow, {Cynthia D.} and Larissa Shamseer and Tetzlaff, {Jennifer M.} and Akl, {Elie A.} and Brennan, {Sue E.} and Roger Chou and Julie Glanville and Grimshaw, {Jeremy M.} and Asbj{\o}rn Hr{\'o}bjartsson and Lalu, {Manoj M.} and Tianjing Li and Loder, {Elizabeth W.} and Evan Mayo-Wilson and Steve McDonald and McGuinness, {Luke A.} and Stewart, {Lesley A.} and James Thomas and Tricco, {Andrea C.} and Welch, {Vivian A.} and Penny Whiting and David Moher",

note = "Funding Information: There was no direct funding for this research. MJP is supported by an Australian Research Council Discovery Early Career Researcher Award (DE200101618) and was previously supported by an Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship (1088535) during the conduct of this research. JEM is supported by an Australian NHMRC Career Development Fellowship (1143429). TCH is supported by an Australian NHMRC Senior Research Fellowship (1154607). JMT is supported by Evidence Partners Inc. JMG is supported by a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake. MML is supported by The Ottawa Hospital Anaesthesia Alternate Funds Association and a Faculty of Medicine Junior Research Chair. TL is supported by funding from the National Eye Institute (UG1EY020522), National Institutes of Health, United States. LAM is supported by a National Institute for Health Research Doctoral Research Fellowship (DRF-2018-11-ST2-048). ACT is supported by a Tier 2 Canada Research Chair in Knowledge Synthesis. DM is supported in part by a University Research Chair, University of Ottawa. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication. Funding Information: There was no direct funding for this research. MJP is supported by an Australian Research Council Discovery Early Career Researcher Award ( DE200101618 ) and was previously supported by an Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship ( 1088535 ) during the conduct of this research. JEM is supported by an Australian NHMRC Career Development Fellowship ( 1143429 ). TCH is supported by an Australian NHMRC Senior Research Fellowship ( 1154607 ). JMT is supported by Evidence Partners Inc . JMG is supported by a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake . MML is supported by The Ottawa Hospital Anaesthesia Alternate Funds Association and a Faculty of Medicine Junior Research Chair . TL is supported by funding from the National Eye Institute ( UG1EY020522 ), National Institutes of Health, United States . LAM is supported by a National Institute for Health Research Doctoral Research Fellowship ( DRF-2018-11-ST2-048 ). ACT is supported by a Tier 2 Canada Research Chair in Knowledge Synthesis . DM is supported in part by a University Research Chair, University of Ottawa . The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication. Publisher Copyright: {\textcopyright} 2021 IJS Publishing Group Ltd Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = apr,

doi = "10.1016/j.ijsu.2021.105906",

language = "English",

volume = "88",

journal = "International Journal of Surgery",

issn = "1743-9191",

publisher = "Elsevier",

}

Page, MJ , McKenzie, JE, Bossuyt, PM, Boutron, I, Hoffmann, TC, Mulrow, CD, Shamseer, L, Tetzlaff, JM, Akl, EA, Brennan, SE, Chou, R, Glanville, J, Grimshaw, JM, Hróbjartsson, A, Lalu, MM, Li, T, Loder, EW, Mayo-Wilson, E, McDonald, S, McGuinness, LA, Stewart, LA, Thomas, J, Tricco, AC, Welch, VA, Whiting, P & Moher, D 2021, 'The PRISMA 2020 statement: An updated guideline for reporting systematic reviews', International Journal of Surgery, vol. 88, 105906. https://doi.org/10.1016/j.ijsu.2021.105906

TY - JOUR

T1 - The PRISMA 2020 statement

T2 - An updated guideline for reporting systematic reviews

AU - Page, Matthew J.

AU - McKenzie, Joanne E.

AU - Bossuyt, Patrick M.

AU - Boutron, Isabelle

AU - Hoffmann, Tammy C.

AU - Mulrow, Cynthia D.

AU - Shamseer, Larissa

AU - Tetzlaff, Jennifer M.

AU - Akl, Elie A.

AU - Brennan, Sue E.

AU - Chou, Roger

AU - Glanville, Julie

AU - Grimshaw, Jeremy M.

AU - Hróbjartsson, Asbjørn

AU - Lalu, Manoj M.

AU - Li, Tianjing

AU - Loder, Elizabeth W.

AU - Mayo-Wilson, Evan

AU - McDonald, Steve

AU - McGuinness, Luke A.

AU - Stewart, Lesley A.

AU - Thomas, James

AU - Tricco, Andrea C.

AU - Welch, Vivian A.

AU - Whiting, Penny

AU - Moher, David

N1 - Funding Information: There was no direct funding for this research. MJP is supported by an Australian Research Council Discovery Early Career Researcher Award (DE200101618) and was previously supported by an Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship (1088535) during the conduct of this research. JEM is supported by an Australian NHMRC Career Development Fellowship (1143429). TCH is supported by an Australian NHMRC Senior Research Fellowship (1154607). JMT is supported by Evidence Partners Inc. JMG is supported by a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake. MML is supported by The Ottawa Hospital Anaesthesia Alternate Funds Association and a Faculty of Medicine Junior Research Chair. TL is supported by funding from the National Eye Institute (UG1EY020522), National Institutes of Health, United States. LAM is supported by a National Institute for Health Research Doctoral Research Fellowship (DRF-2018-11-ST2-048). ACT is supported by a Tier 2 Canada Research Chair in Knowledge Synthesis. DM is supported in part by a University Research Chair, University of Ottawa. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication. Funding Information: There was no direct funding for this research. MJP is supported by an Australian Research Council Discovery Early Career Researcher Award ( DE200101618 ) and was previously supported by an Australian National Health and Medical Research Council (NHMRC) Early Career Fellowship ( 1088535 ) during the conduct of this research. JEM is supported by an Australian NHMRC Career Development Fellowship ( 1143429 ). TCH is supported by an Australian NHMRC Senior Research Fellowship ( 1154607 ). JMT is supported by Evidence Partners Inc . JMG is supported by a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake . MML is supported by The Ottawa Hospital Anaesthesia Alternate Funds Association and a Faculty of Medicine Junior Research Chair . TL is supported by funding from the National Eye Institute ( UG1EY020522 ), National Institutes of Health, United States . LAM is supported by a National Institute for Health Research Doctoral Research Fellowship ( DRF-2018-11-ST2-048 ). ACT is supported by a Tier 2 Canada Research Chair in Knowledge Synthesis . DM is supported in part by a University Research Chair, University of Ottawa . The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication. Publisher Copyright: © 2021 IJS Publishing Group Ltd Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/4

Y1 - 2021/4

N2 - The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.

AB - The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.

UR - http://www.scopus.com/inward/record.url?scp=85103772186&partnerID=8YFLogxK

U2 - 10.1016/j.ijsu.2021.105906

DO - 10.1016/j.ijsu.2021.105906

M3 - Article

C2 - 33789826

AN - SCOPUS:85103772186

SN - 1743-9191

VL - 88

JO - International Journal of Surgery

JF - International Journal of Surgery

M1 - 105906

ER -

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

Abstract

Access to Document

Other files and links